2015 中国黄褐斑治疗专家共识

2016-08-15 中华皮肤科杂志.2016,49(8):529-532.

中国中西医结合学会皮肤性病专业委员会色素病学组于1994年制定了《黄褐斑的临床诊断和疗效判定标准》,其后于2003年和2009年又做了两次修订。2015年12月,中国中西医结合学会皮肤性病专业委员会色素病学组、中华医学会皮肤性病学分会白癜风研究中心、中国医师协会皮肤科医师分会色素病工作组,在杭州共同修改制订了中国黄褐斑治疗专家共识(2015版)。 黄褐斑(melasma)是一种面部获得性色素增加

中文标题:

2015 中国黄褐斑治疗专家共识

发布机构:

发布日期:

2016-08-15

简要介绍:

中国中西医结合学会皮肤性病专业委员会色素病学组于1994年制定了《黄褐斑的临床诊断和疗效判定标准》,其后于2003年和2009年又做了两次修订。2015年12月,中国中西医结合学会皮肤性病专业委员会色素病学组、中华医学会皮肤性病学分会白癜风研究中心、中国医师协会皮肤科医师分会色素病工作组,在杭州共同修改制订了中国黄褐斑治疗专家共识(2015版)。  黄褐斑(melasma)是一种面部获得性色素增加性皮肤病,多发生于频繁暴露于紫外线下肤色较深的女性面部。皮疹常分布对称,发展缓慢,可持续多年。其发病机制尚未完全阐明,治疗困难,易复发。 

制定者: 
中国中西医结合学会皮肤性病专业委员会色素病学组 
中华医学会皮肤性病学分会白癜风研究中心 
中国医师协会皮肤科医师分会色素病工作组 

拓展指南:黄褐斑相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2015 中国黄褐斑治疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=97c321c00125e3f4, title=2015 中国黄褐斑治疗专家共识, enTitle=, guiderFrom=中华皮肤科杂志.2016,49(8):529-532., authorId=null, author=, summary=中国中西医结合学会皮肤性病专业委员会色素病学组于1994年制定了《黄褐斑的临床诊断和疗效判定标准》,其后于2003年和2009年又做了两次修订。2015年12月,中国中西医结合学会皮肤性病专业委员会色素病学组、中华医学会皮肤性病学分会白癜风研究中心、中国医师协会皮肤科医师分会色素病工作组,在杭州共同修改制订了中国黄褐斑治疗专家共识(2015版)。 黄褐斑(melasma)是一种面部获得性色素增加, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Aug 15 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<div>中国中西医结合学会皮肤性病专业委员会色素病学组于1994年制定了《黄褐斑的临床诊断和疗效判定标准》,其后于2003年和2009年又做了两次修订。2015年12月,中国中西医结合学会皮肤性病专业委员会色素病学组、中华医学会皮肤性病学分会白癜风研究中心、中国医师协会皮肤科医师分会色素病工作组,在杭州共同修改制订了中国黄褐斑治疗专家共识(2015版)。  黄褐斑(melasma)是一种面部获得性色素增加性皮肤病,多发生于频繁暴露于紫外线下肤色较深的女性面部。皮疹常分布对称,发展缓慢,可持续多年。其发病机制尚未完全阐明,治疗困难,易复发。<span style="font-size: 9pt;"> </span></div> <div><br> </div> <div><span style="font-weight: bold;">制定者:</span> </div> <div>中国中西医结合学会皮肤性病专业委员会色素病学组 </div> <div>中华医学会皮肤性病学分会白癜风研究中心 </div> <div>中国医师协会皮肤科医师分会色素病工作组 </div> <br> 拓展指南:<strong>与<font color=red>黄褐斑</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=97c321c00125e3f4" title="2015 中国黄褐斑治疗专家共识" target=_blank>2015 中国黄褐斑治疗专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%BB%84%E8%A4%90%E6%96%91" target=_blank>有关黄褐斑更多指南</a></ul>, tagList=[TagDto(tagId=37107, tagName=黄褐斑)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14550, appHits=502, showAppHits=5, pcHits=6620, showPcHits=8800, likes=82, shares=11, comments=5, approvalStatus=1, publishedTime=Mon Aug 22 11:10:38 CST 2016, publishedTimeString=2016-08-15, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Aug 22 11:10:38 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:52:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2015 中国黄褐斑治疗专家共识)])
2015 中国黄褐斑治疗专家共识
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2173960, encodeId=ac9521e39606d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:49:41 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1056104, encodeId=3d31105610420, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Wed Sep 29 13:51:34 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914296, encodeId=b1b49142963d, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1620132, createdName=jxx100, createdTime=Thu Jan 07 08:50:34 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106995, encodeId=6d3410699524, content=色素性皮肤病在用氨甲环酸的量上国内和国外还是有点不一致的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:52:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106994, encodeId=a92810699446, content=色素性皮肤病的治疗需要和国际接轨才能走出更好的治疗途径!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:39:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]
    2023-12-10 ms6000000013039699 来自河北省

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2173960, encodeId=ac9521e39606d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:49:41 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1056104, encodeId=3d31105610420, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Wed Sep 29 13:51:34 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914296, encodeId=b1b49142963d, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1620132, createdName=jxx100, createdTime=Thu Jan 07 08:50:34 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106995, encodeId=6d3410699524, content=色素性皮肤病在用氨甲环酸的量上国内和国外还是有点不一致的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:52:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106994, encodeId=a92810699446, content=色素性皮肤病的治疗需要和国际接轨才能走出更好的治疗途径!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:39:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]
    2021-09-29 1477308bm10(暂无昵称)

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2173960, encodeId=ac9521e39606d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:49:41 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1056104, encodeId=3d31105610420, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Wed Sep 29 13:51:34 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914296, encodeId=b1b49142963d, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1620132, createdName=jxx100, createdTime=Thu Jan 07 08:50:34 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106995, encodeId=6d3410699524, content=色素性皮肤病在用氨甲环酸的量上国内和国外还是有点不一致的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:52:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106994, encodeId=a92810699446, content=色素性皮肤病的治疗需要和国际接轨才能走出更好的治疗途径!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:39:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]
    2021-01-07 jxx100

    学习了!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2173960, encodeId=ac9521e39606d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:49:41 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1056104, encodeId=3d31105610420, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Wed Sep 29 13:51:34 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914296, encodeId=b1b49142963d, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1620132, createdName=jxx100, createdTime=Thu Jan 07 08:50:34 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106995, encodeId=6d3410699524, content=色素性皮肤病在用氨甲环酸的量上国内和国外还是有点不一致的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:52:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106994, encodeId=a92810699446, content=色素性皮肤病的治疗需要和国际接轨才能走出更好的治疗途径!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:39:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]
    2016-08-29 1e0f4749m27(暂无匿称)

    色素性皮肤病在用氨甲环酸的量上国内和国外还是有点不一致的!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2173960, encodeId=ac9521e39606d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:49:41 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1056104, encodeId=3d31105610420, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Wed Sep 29 13:51:34 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914296, encodeId=b1b49142963d, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1620132, createdName=jxx100, createdTime=Thu Jan 07 08:50:34 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106995, encodeId=6d3410699524, content=色素性皮肤病在用氨甲环酸的量上国内和国外还是有点不一致的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:52:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106994, encodeId=a92810699446, content=色素性皮肤病的治疗需要和国际接轨才能走出更好的治疗途径!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeae1942301, createdName=1e0f4749m27(暂无匿称), createdTime=Mon Aug 29 21:39:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]
    2016-08-29 1e0f4749m27(暂无匿称)

    色素性皮肤病的治疗需要和国际接轨才能走出更好的治疗途径!

    0